Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.68    0.03 (0.65%)
Bid:
4.61
Ask:
4.655
Spread: 0.045 (0.976%)
Market Cap: £224.62m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

Director & Senior Manager Share Awards

28 Apr 2011 13:44

RNS Number : 6633F
Seeing Machines Limited
28 April 2011
 



28 April 2011

 

 

SEEING MACHINES LIMITED

 

DIRECTOR & Senior Manager SHARE AWARDS

Seeing Machines Limited (AIM:SEE), a leading developer of advanced computer based imaging software systems announces that it has today issued 767,099 new fully paid ordinary shares ("New Ordinary Shares") to certain Directors and senior managers under the July 2010 Executive Share Plan which was approved at the Annual General Meeting in November 2010. All shares issued under the plan are based on a salary/fee sacrifice arrangement.

Under the plan the Directors' received shares as follows:

Director

Number of New Ordinary Shares

Holding following receipt of New Ordinary Shares

Percentage holding following receipt of New Ordinary Shares

Robert Charles Sale 1

120,724

5,487,808

1.34%

Nicholas John Cerneaz2

188,631

2,049,044

0.50%

David John Gaul 3

60,362

2,020,948

0.49%

Trent William Victor

60,362

236,236

0.06%

1. Robert Sales shares are 2,745,715 shares held in the name of Caffe Pty Ltd ATF the R C Sale Superannuation Fund, 2,621,369 shares held by Robert's wife Paula Kay Sale and 120,724 shares held in his own name.

2. Nicholas John Cerneaz holds 1,467,332 shares through Cenika Pty Ltd ATF Cenika Super Fund and 581,712 in his own name.

3. David Gaul holds 2,020,948 shares through his company Jaiclimb Pty Limited.

Under the Plan the following senior managers received shares as follows:

Senior Manager

Role

Number of New Ordinary Shares

Holding following receipt of New Ordinary Shares

Percentage holding following receipt of New Ordinary Shares

Belinda Burgess 4

COO & Company Secretary

186,116

2,401,550

0.59%

Timothy Edwards

Principal Engineer

75,452

21,681,316

5.30%

Sebastien Rougeaux

Principal Research Scientist

75,452

22,174,792

5.42%

4. Belinda Burgess holds 965,870 shares in her own name and 1,435,680 shares in the names Belinda Burgess and Jennifer Kruse as trustees for the Meg & Susie Super Fund.

Application has been made for the New Ordinary Shares to be admitted to trading on AIM. It is expected that admission will occur and that dealings will commence at 8.00 a.m. on 6 May 2011. Immediately following admission of the New Ordinary Shares, the Company will have 408,908,546 fully paid ordinary shares on issue.

 

Enquiries:

 

Seeing Machines Limited

Nick Cerneaz, CEO +61 (0) 2 6103 4700

Daniel Stewart & Company plc

Oliver Rigby +44 (0) 20 7776 6550

Walbrook PR Ltd

Bob Huxford +44 (0) 20 7933 8783

Helen Westaway +44 (0) 20 7933 8790

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSDMGZDZRZGMZM
Date   Source Headline
12th May 20267:00 amRNSUS$3.8m Order for Guardian BdMS
6th May 20267:00 amRNSQ3 FY2026 Quarterly KPIs
20th Apr 202612:30 pmRNSHolding(s) in Company
10th Apr 20268:53 amRNSStatement re alleged cyber threat
27th Mar 20267:00 amRNSHalf-year Financial Report
24th Feb 20267:00 amRNS-RPublication of Investor Presentation
18th Feb 20267:00 amRNSTrading Update - H1 FY2026
13th Feb 20267:30 amRNSAppointment of Joint Broker
11th Feb 20267:00 amRNSQ2 FY2026 Quarterly KPIs
13th Jan 202612:00 pmRNS-R3D Cabin Perception Mapping breaks new ground
6th Jan 20267:00 amRNSAgreement
5th Jan 20267:00 amRNS-R3D Cabin Perception Mapping to be unveiled at CES
5th Jan 20267:00 amRNSHolding(s) in Company
2nd Jan 20267:00 amRNS-RSeeing Machines Announces Future Mobility Group
2nd Jan 20267:00 amRNS-RSeeing Machines Announces Future Mobility Group
17th Dec 20257:00 amRNS-RTechnical Paper Series - Intoxication launched
4th Dec 20257:00 amRNS-RSeeing Machines 2025 Guardian Insights Report
27th Nov 20257:00 amRNSResults of AGM
26th Nov 20257:30 amRNSJapanese Auto Award and Extended European Program
12th Nov 20257:05 amRNSQ1 FY2026 Quarterly KPIs
12th Nov 20257:00 amRNSGuardian order from US-based multinational company
6th Nov 20257:05 amRNS-RCollaboration with Magna milestone in China
3rd Nov 20257:00 amRNSBoard Changes
3rd Nov 20257:00 amRNSNotice of Annual General Meeting
30th Oct 20257:00 amRNSLATAM Distributor Orders 1,300 Guardian Units
29th Oct 20257:00 amRNSAdvanced Development Project with Japanese OEM
8th Oct 20257:00 amRNSUS$1.8m expansion order for Guardian BdMS
26th Sep 20257:00 amRNSExpanding Guardian prospects across Europe
25th Sep 20257:00 amRNSFY2025 Results and Annual Financial Report
24th Sep 20257:20 amRNSFirst Guardian contract through Mitsubishi
10th Sep 20257:05 amRNS-RSeeing Machines Launches Impairment Capability
10th Sep 20257:00 amRNSNotice of Results and Presentation
29th Aug 202510:10 amRNSDirector Dealing
21st Aug 20257:00 amRNSFY2025 Trading Update
5th Aug 20257:00 amRNSQ4 FY2025 Quarterly KPIs
30th Jun 20257:00 amRNSMitsubishi Electric Europe Guardian collaboration
27th Jun 20257:00 amRNSUS Guardian Gen 3 trial with Mitsubishi Electric
16th Jun 20258:59 amRNS$1.2 Million Agreement with Global Auto Leader
9th May 20252:31 pmRNSDirector dealing
1st May 20257:00 amRNSQ3 FY2025 Quarterly KPIs
29th Apr 20259:58 amRNSNotification of Major Holdings
8th Apr 20258:53 amRNSHoldings in Company
8th Apr 20257:00 amRNSDirector/PDMR Shareholding
4th Apr 20257:00 amRNSDirector dealing
2nd Apr 202511:00 amRNSLondon presentation for investors and analysts
2nd Apr 20257:00 amRNSDirector dealing
2nd Apr 20257:00 amRNSDirector dealing
1st Apr 202512:00 pmRNS-RSeeing Machines Announces 3D Camera Technology
31st Mar 20257:00 amRNSDirector/PDMR Shareholding
28th Mar 20257:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.